FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, in particular, to pulmonology and resuscitation, and is intended for treating non-cardiogenic pulmonary oedema. An aqueous 1% solution of hydrochloride N,N-diethyl-5.5-diphenyl-2-pentinylamine, injected in the form of an aerosol with a particle distribution range from 0.2 to 8 microns, is used as a treatment agent.
EFFECT: invention ensures a significant increase in the effectiveness of treatment of non-cardiogenic pulmonary oedema.
1 cl, 1 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF AN ALPHA1-PROTEINASE INHIBITOR (ALPHA1-ANTITRYPSIN) FOR PREVENTION AND/OR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME AND METHOD FOR PREVENTION AND/OR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME USING ALPHA1-ANTITRYPSIN | 2020 |
|
RU2757875C1 |
| PHARMACEUTICAL COMPOSITION BASED ON GLUCOCORTICOSTEROID BUDESONIDE AND PHOSPHATIDYLCHOLINE FOR DRY INHALATION | 2019 |
|
RU2730488C1 |
| USE OF ENISAMIUM IODIDE FOR THE PREVENTION AND/OR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) | 2022 |
|
RU2799328C1 |
| METHOD FOR STIMULATING ACUTE PULMONARY INJURY | 2010 |
|
RU2456677C2 |
| METHOD OF REHABILITATION, COMBINING HYPO- AND HYPERBARIC OXYGENATION, FOR PATIENTS SUFFERING NEW CORONAVIRUS INFECTION | 2023 |
|
RU2821549C1 |
| METHOD FOR OPTIMISING ARTICULAR CARTILAGE CONDITION ACCOMPANYING EXPERIMENTAL IMMOBILISATION OSTEOPOROSIS | 2013 |
|
RU2547787C1 |
| REMEDY FOR POISONING AND ITS COMPLICATIONS TREATMENT | 2006 |
|
RU2331417C1 |
| METHOD OF TREATMENT OF ADULT PATIENTS WITH RESPIRATORY DISTRESS SYNDROME | 1999 |
|
RU2149016C1 |
| METHOD FOR DIFFERENTIATED PRESCRIPTION OF HYPERBARIC OXYGENATION AT PULMONARY CANCER | 2003 |
|
RU2255338C1 |
| METHOD FOR TREATING ARTERIAL HYPERTENSION BY INHALATION DELIVERY OF HYPOTENSIVE PREPARATION AEROSOL | 2014 |
|
RU2593016C2 |
